These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16129253)

  • 21. Contrast media hypersensitivity--scope of the problem.
    Brockow K
    Toxicology; 2005 Apr; 209(2):189-92. PubMed ID: 15767034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PGE suppresses excessive anti-IgE induced cysteinyl leucotrienes production in mast cells of patients with aspirin exacerbated respiratory disease.
    Wang XS; Wu AY; Leung PS; Lau HY
    Allergy; 2007 Jun; 62(6):620-7. PubMed ID: 17508965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Oral administration of intravenous contrast media: a tasty alternative to conventional oral contrast media in computed tomography].
    Diederichs G; Franiel T; Asbach P; Romano V; Hamm B; Rogalla P
    Rofo; 2007 Oct; 179(10):1061-7. PubMed ID: 17786895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxidative stress and lipid-derived inflammatory mediators during acute exacerbations of cystic fibrosis.
    Reid DW; Misso N; Aggarwal S; Thompson PJ; Walters EH
    Respirology; 2007 Jan; 12(1):63-9. PubMed ID: 17207027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Universal use of nonionic iodinated contrast medium for CT: evaluation of safety in a large urban teaching hospital.
    Mortelé KJ; Oliva MR; Ondategui S; Ros PR; Silverman SG
    AJR Am J Roentgenol; 2005 Jan; 184(1):31-4. PubMed ID: 15615946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and nephrologic tolerance of iopromide and iotrolan in computed tomography.
    Langer M; Langer R; Zwicker C; Speck U; Jänicke UA; Felix R
    Invest Radiol; 1991 Nov; 26 Suppl 1():S83-5; discussion S88-91. PubMed ID: 1808156
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of the nonionic contrast agents, iopromide and iotrolan, for positive-contrast arthrography of the scapulohumeral joint in dogs.
    van Bree H; Van Rijssen B; Tshamala M; Maenhout T
    Am J Vet Res; 1992 Sep; 53(9):1622-6. PubMed ID: 1416366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased in vitro histamine release by radiographic contrast media in patients with history of incompatibility.
    Ring J; Simon RA; Arroyave CM
    Clin Exp Immunol; 1978 Nov; 34(2):302-9. PubMed ID: 83924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intranasal steroid reduces exhaled bronchial cysteinyl leukotrienes in allergic patients.
    Failla M; Biondi G; Provvidenza Pistorio M; Gili E; Mastruzzo C; Vancheri C; Crimi N
    Clin Exp Allergy; 2006 Mar; 36(3):325-30. PubMed ID: 16499643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contrast enhancement in chest multidetector computed tomography: intraindividual comparison of 300 mg/ml versus 400 mg/ml iodinated contrast medium.
    Behrendt FF; Plumhans C; Keil S; Mühlenbruch G; Das M; Seidensticker P; Mutscher C; Günther RW; Mahnken AH
    Acad Radiol; 2009 Feb; 16(2):144-9. PubMed ID: 19124099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contrast media and nephropathy: findings from systematic analysis and Food and Drug Administration reports of adverse effects.
    Solomon R; Dumouchel W
    Invest Radiol; 2006 Aug; 41(8):651-60. PubMed ID: 16829749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What are radiologists doing to prevent contrast-induced nephropathy (CIN) compared with measures supported by current evidence? A survey of European radiologists on CIN associated with computed tomography.
    Fishman EK; Reddan D
    Acta Radiol; 2008 Apr; 49(3):310-20. PubMed ID: 18365820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sensation of smell and taste during intravenous injection of iodinated contrast media in CT examinations.
    Yamaguchi N; Fukushima Y; Yamaguchi A; Nagasawa N; Taketomi-Takahashi A; Suto T; Tsushima Y
    Br J Radiol; 2017 Jan; 90(1069):20160629. PubMed ID: 27805431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A case of Iotrolan encephalopathy].
    Suga T; Goto H; Yoshioka K; Hosoya T
    No Shinkei Geka; 1996 Nov; 24(11):1051-4. PubMed ID: 8934476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonionic iodinated contrast media reactions.
    Lasser EC
    AJR Am J Roentgenol; 2009 Feb; 192(2):W80; author reply W81. PubMed ID: 19155387
    [No Abstract]   [Full Text] [Related]  

  • 36. Prospective evaluation of adverse reactions to iodine-containing contrast media after ERCP.
    Draganov PV; Forsmark CE
    Gastrointest Endosc; 2008 Dec; 68(6):1098-101. PubMed ID: 19028218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Iopentol (Imagopaque 300) compared with iopromide (Ultravist 300) in abdominal CT. A multi-centre monitoring trial assessing adverse events and diagnostic information--results from 518 patients in Spain.
    Encina JL; Martí-Bonmatí L; Ronchera-Oms CL; Rodríguez V
    Eur Radiol; 1997; 7 Suppl 4():S115-9. PubMed ID: 9204351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequency, outcome, and appropriateness of treatment of nonionic iodinated contrast media reactions.
    Wang CL; Cohan RH; Ellis JH; Caoili EM; Wang G; Francis IR
    AJR Am J Roentgenol; 2008 Aug; 191(2):409-15. PubMed ID: 18647910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iopromide versus diatrizoate. A comparative study of adverse reactions.
    Skovgaard N; Jensen ER; Jakobsen KP
    Acta Radiol; 1990 Sep; 31(5):537-8. PubMed ID: 2261306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Skin testing in patients with hypersensitivity reactions to iodinated contrast media - a European multicenter study.
    Brockow K; Romano A; Aberer W; Bircher AJ; Barbaud A; Bonadonna P; Faria E; Kanny G; Lerch M; Pichler WJ; Ring J; Rodrigues Cernadas J; Tomaz E; Demoly P; Christiansen C;
    Allergy; 2009 Feb; 64(2):234-41. PubMed ID: 19178403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.